Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors

Kimio Yonesaka, Eiji Iwama, Hidetoshi Hayashi, Shinichiro Suzuki, Ryoji Kato, Satomi Watanabe, Takayuki Takahama, Junko Tanizaki, Kaoru Tanaka, Masayuki Takeda, Kazuko Sakai, Koichi Azuma, Yasutaka Chiba, Shinji Atagi, Kazuto Nishio, Isamu Okamoto, Kazuhiko Nakagawa

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science